IP Group news 0

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the UK's leading
university intellectual property commercialisation company, announces that it has today received notification from Alan Aubrey, Chief Executive Officer, and David Norwood,
Special Projects Director, regarding the purchase of Ordinary Shares in the Company.

The Company was notified on 25 November 2008 that Alan Aubrey, Chief Executive Officer, purchased in aggregate 62,000 Ordinary Shares in the Company at 33.5 pence per share.

The Company was notified on 25 November 2008 that David Norwood, Special Projects
Director, purchased in aggregate 308,000 Ordinary Shares in the Company at 33.5 pence per share.

The full text of this announcement is available on RNS.

For further information, please contact:

IP Group plc                           
    Alan Aubrey, Chief Executive Officer              020 7444 0050
    Liz Vaughan-Adams (Communications)        020 7444 0062/07979853802

Financial Dynamics
    Ben Atwell, John Dineen                                  020 7831 3113

Notes for Editors

About IP Group

IP Group is an intellectual property (IP) commercialisation company that specialises in
commercialising university technology. Founded in 2001, IP Group listed on AIM in October 2003 and moved to the Official List in June 2006. It has made two acquisitions to date -Techtran, a company set up to commercialise university intellectual property under a long term contract with the University of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early stage technology venture capital funds, in 2004.

IP Group has formed long-term partnerships with ten universities - the University of
Oxford, King's College London, CNAP/University of York, the University of Leeds, the University of Bristol, the University of Surrey, the University of Southampton, Queen Mary (University of London), the University of Bath and the University of Glasgow.

The Company's portfolio is diverse with exposure to five main sectors - Energy &
Renewables, Healthcare & Life Sciences: Non-therapeutics, Healthcare & Life Sciences: Therapeutics, IT & Communications and Chemicals & Materials. To date, ten portfolio companies have listed on the AIM market of the London Stock Exchange, one on PLUS Markets and there have been two trade sales. IP Group also established three 'Modern-themed' subsidiaries - Modern Biosciences, Modern Water and Modern Waste. Modern Water was the first of these subsidiaries to float on AIM in June 2007.

For more information, please visit our website at www.ipgroupplc.com.